WebOct 3, 2024 · LogicBio has developed technology platforms for the delivery and insertion of genes to address genetic diseases, as well as a platform designed to improve viral … WebOct 3, 2024 · LogicBio® Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood.
EX-99.1 - SEC
WebNov 16, 2024 · LogicBio acquisition to build on current collaborations and advancements in genomic medicine WILMINGTON, Del., November 16, 2024 – Alexion, AstraZeneca … WebMay 11, 2024 · LEXINGTON, Mass., May 11, 2024 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC ), a clinical-stage genetic medicine company, today announced that it will present four abstracts... i knew the bride nick lowe
LogicBio Therapeutics - Pioneering Genetic Medicine
WebNov 15, 2024 · On September 12, 2024, Cecilia Jones, the Chief Financial Officer of LogicBio Therapeutics, Inc. (the “Company”), notified the Company of her intent to resign … WebOct 3, 2024 · LogicBio is part of a new contingent of companies developing alternative approaches to gene editing. Most gene editing technologies employ a cutting enzyme to snip DNA at a targeted location.... WebOct 3, 2024 · Oct 3 (Reuters) - Shares of LogicBio Therapeutics (LOGC.O) skyrocketed on Monday after Britain's AstraZeneca's (AZN.L) said it would buy the U.S.-based gene therapy developer at a rare 660%... i love hand to hand cadence